The role of iron in the pathophysiology and treatment of chronic hepatitis C.

Increased hepatic iron content may be observed in patients with chronic hepatitis C infection, and may contribute to disease severity. The presence of hemochromatosis gene mutations is associated with increased hepatic iron accumulation and may lead to accelerated disease progression. Hepatic iron depletion has been postulated to decrease the risk of hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C. It is possible that iron depletion stabilizes or improves liver histology and slows disease progression in these individuals. The present article reviews the prevalence and risk factors for hepatic iron overload in chronic hepatitis C, with emphasis on the available data regarding the efficacy of iron depletion in the treatment of this common liver disease.

• Publication year

  2009

• Venue

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie

• Publication date

  2009-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1155/2009/290383PMID 20011735PMCID PMC2805519
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription

  2008cited by this paper
• Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription.

  2008cited by this paper
• HCV, iron, and oxidative stress: the new choreography of hepcidin.

  2008cited by this paper
• Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C

  2008cited by this paper
• Hepatic oxidative DNA damage is associated with increased risk for hepatocellular carcinoma in chronic hepatitis C

  2008cited by this paper
• Phlebotomy Improves Therapeutic Response to Interferon in Patients with Chronic Hepatitis C: A Meta-Analysis of Six Prospective Randomized Controlled Trials

  2008cited by this paper
• Iron stores, response to alpha-interferon therapy, and effects of iron depletion in chronic hepatitis C.

  2008cited by this paper
• Effects of dietary iron reduction versus phlebotomy in patients with chronic hepatitis C: results from a randomized, controlled trial on 40 Japanese patients.

  2007cited by this paper
• Long-term phlebotomy with low-iron diet therapy lowers risk of development of hepatocellular carcinoma from chronic hepatitis C

  2007influential reference
• Prevalence of hepatic iron overload and association with hepatocellular cancer in end‐stage liver disease: results from the National Hemochromatosis Transplant Registry

  2007cited by this paper
• Iron, haemochromatosis and thalassaemia as risk factors for fibrosis in hepatitis C virus infection

  2007cited by this paper
• Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C

  2007cited by this paper
• Effect of iron depletion on serum markers of fibrogenesis, oxidative stress and serum liver enzymes in chronic hepatitis C: results of a pilot study

  2007cited by this paper
• Hepcidin Expression in the Liver: Relatively Low Level in Patients with Chronic Hepatitis C

  2007cited by this paper
• Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein.

  2006cited by this paper
• Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C.

  2006cited by this paper
• Relationships between Hepatic Iron Content and Virologic Response in Chronic Hepatitis C Patients Treated with Interferon and Ribavirin

  2005cited by this paper
• Determinants of serum ALT normalization after phlebotomy in patients with chronic hepatitis C infection

  2005cited by this paper
• Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C

  2004cited by this paper
• Iron, hemochromatosis, and hepatocellular carcinoma.

  2004cited by this paper
• Hepatic stellate cells in hepatitis C patients: Relationship with liver iron deposits and severity of liver disease

  2004cited by this paper
• Hepatic iron concentration does not predict response to standard and pegylated-IFN/ribavirin therapy in patients with chronic hepatitis C.

  2004influential reference
• A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan

  2004influential reference
• Lack of association between HFE gene mutations and hepatocellular carcinoma in patients with cirrhosis

  2003influential reference
• HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis.

  2003influential reference
• Hepatitis C, iron status, and disease severity: relationship with HFE mutations.

  2003cited by this paper
• HFE C282Y heterozygosity in hepatocellular carcinoma: evidence for an increased prevalence.

  2003influential reference
• Mutations of the HFE Gene in Patients With Hepatocellular Carcinoma

  2003cited by this paper
• Iron depletion and response to interferon in chronic hepatitis C.

  2003influential reference
• Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype

  2003influential reference
• Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C.

  2002cited by this paper
• HFE gene mutations prevent sustained virological response to interferon plus ribavirin in chronic hepatitis C patients with serum markers of iron overload

  2002cited by this paper
• Long term effects of phlebotomy on biochemical and histological parameters of chronic hepatitis C

  2002cited by this paper
• HFE gene mutations in alcoholic and virus-related cirrhotic patients with hepatocellular carcinoma

  2002cited by this paper
• Iron reduction and sustained response to interferon-α therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study

  2002cited by this paper
• Hepatic Iron Concentration Does Not Influence Response to Therapy with Interferon Plus Ribavirin in Chronic HCV Infection

  2002cited by this paper
• The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C

  2002cited by this paper
• Normalization of elevated hepatic 8-hydroxy-2'-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet.

  2001cited by this paper
• Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: A multicenter, prospective, randomized, controlled trial

  2000influential reference
• Iron deposition and progression of disease in chronic hepatitis C. Role of interface hepatitis, portal inflammation, and HFE missense mutations.

  2000cited by this paper
• Beneficial influence of an indigenous low-iron diet on serum indicators of iron status in patients with chronic liver disease

  2000cited by this paper
• Iron reduction before and during interferon therapy of chronic hepatitis C: Results of a multicenter, randomized, controlled trial

  2000influential reference
• C282Y mutation and hepatic iron status in hepatitis C and cryptogenic cirrhosis.

  2000cited by this paper
• Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis

  2000cited by this paper
• Liver iron excess in patients with hepatocellular carcinoma developed on viral C cirrhosis

  2000influential reference
• Heterozygosity for the hemochromatosis gene in liver diseases--prevalence and effects on liver histology.

  2000cited by this paper
• A pilot study of iron depletion as adjuvant therapy in chronic hepatitis C patients not responding to interferon

  1999influential reference
• Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions.

  1999influential reference
• The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C.

  1999cited by this paper
• Interferon Alfa-2b Alone or in Combination with Ribavin as Intial Treatment for Chronic Hepatitis C

  1998cited by this paper
• Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C

  1998cited by this paper
• Hepatic iron overload in patients with chronic viral hepatitis: Role of HFE gene mutations

  1998influential reference
• Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.

  1998cited by this paper
• Hepatitis C

  1998cited by this paper
• A pilot randomized, controlled trial of the effect of iron depletion on long-term response to α-interferon in patients with chronic hepatitis C

  1998cited by this paper
• A pilot randomized, controlled trial of the effect of iron depletion on long-term response to alpha-interferon in patients with chronic hepatitis C.

  1998cited by this paper
• Iron and chronic viral hepatitis

  1997cited by this paper
• Effect of iron depletion on long-term response to interferon-alpha in patients with chronic hepatitis C who previously did not respond to interferon therapy.

  1997influential reference
• Retreatment of hepatitis C interferon non-responders with larger doses of interferon with and without phlebotomy.

  1996influential reference
• Relationship between hepatic iron deposits and response to interferon in chronic hepatitis C.

  1996cited by this paper
• Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C.

  1995cited by this paper
• Response to interferon α therapy is influenced by the iron content of the liver

  1994cited by this paper
• Response to interferon alpha therapy is influenced by the iron content of the liver.

  1994cited by this paper
• Measurements of iron status in patients with chronic hepatitis.

  1992influential reference

• Diagnostic yield of whole exome sequencing in adult-onset cholestatic liver disease.

  2025cites this paper
• rs55959738 is Associated with Hepcidin in Metabolic Dysfunction‐Associated Steatotic Liver Disease

  2025cites this paper
• Effects of Gamisoyo-San, a Traditional Herbal Medicine, on Antioxidant Phase II Enzymes via Akt-Erk-Nrf2 Pathway

  2025cites this paper
• Hepatitis B Virus‐Associated Liver Carcinoma: The Role of Iron Metabolism and Its Modulation

  2024cites this paper
• Relationship between iron overload caused by abnormal hepcidin expression and liver disease: A review

  2023cites this paper
• Tocilizumab Treatment Effect on Iron Homeostasis in Severe COVID-19 Patients

  2022cites this paper
• Coordination of AMPK and YAP by Spatholobi Caulis and Procyanidin B2 Provides Antioxidant Effects In Vitro and In Vivo

  2022cites this paper
• Iron overload disorders

  2022cites this paper
• Co-infections as Modulators of Disease Outcome: Minor Players or Major Players?

  2021cites this paper
• Transforming a clinical fluorescent dye to sense and treat iron overload disorders: a new reverse translational approach in precision medicine.

  2021cites this paper
• Correlation Between HCV Infection and Creatinine Level in Thalassemia Patents

  2020cites this paper
• Determination of mutations in iron regulating genes of beta thalassemia major patients of Khyber Pakhtunkhwa, Pakistan

  2020influential citation
• Serum hepcidin levels are related to serum markers for iron metabolism and fibrosis stage in patients with chronic hepatitis B: A cross-sectional study.

  2020cites this paper
• Insulin Resistance and Chronic Hepatitis C: Relationship With Serum Iron and Hepcidin

  2020cites this paper
• MicroRNA profile and iron-related gene expression in hepatitis C-related hepatocellular carcinoma: a preliminary study

  2019cites this paper
• Role of iron in cancer development by viruses

  2019cites this paper
• “Double Punch”: Hepatitis C in Patients with Genetic Defects of Iron Metabolism

  2019cites this paper
• Noninvasive Differential Diagnosis of Liver Iron Contents in Nonalcoholic Steatohepatitis and Simple Steatosis Using Multiecho Dixon Magnetic Resonance Imaging.

  2019cites this paper
• Liver clear cell foci and viral infection are associated with non-cirrhotic, non-fibrolamellar hepatocellular carcinoma in young patients from South America

  2018cites this paper
• Can Serum Iron Parameters Represent Surrogate Markers for Chronic Hepatitis C-Based Hepatocellular Carcinoma?

  2018cites this paper
• Chapter 6 Hepatitis C Virus in Thalassemia

  2018cites this paper
• The role of diffusion‐weighted imaging in prediction liver iron concentration in beta‐thalassaemia patients

  2018cites this paper
• Hepatitis C Virus in Thalassemia

  2018cites this paper
• Serum Markers of Iron Metabolism in Chronic Liver Diseases

  2018cites this paper
• Relationship between Hepatitis C Virus Infection and Iron Overload

  2017cites this paper
• Porphyria cutanea tarda: an intriguing genetic disease and marker

  2017cites this paper
• Liqustri lucidi Fructus inhibits hepatic injury and functions as an antioxidant by activation of AMP-activated protein kinase in vivo and in vitro.

  2017cites this paper
• Diffusion-weighted imaging of the liver: Current applications

  2016cites this paper
• Interferon lambda polymorphisms associate with body iron indices and hepatic expression of interferon-responsive long non-coding RNA in chronic hepatitis C

  2016cites this paper
• Elevated serum &agr;-fetoprotein levels in patients with chronic hepatitis C virus genotype 4: not the end of the story

  2016cites this paper
• Iron Overload in Patients With Chronic Liver Disease.

  2016cites this paper
• Molecular pathogenesis and clinical consequences of iron overload in liver cirrhosis.

  2016cites this paper
• Serum Ferritin and Transferrin as Biomarkers for Liver Fibrosis Appreciated using Transient Hepatic Elastography ( TE ) by Fibro Scan in Egyptian Patients with Chronic Hepatitis C Virus

  2016cites this paper
• Iron deposition causes oxidative stress, inflammation and fibrosis in carbon tetrachloride-induced liver dysfunction in rats

  2015cites this paper
• Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus-infected liver.

  2015cites this paper
• Quantitative T2* magnetic resonance imaging for renal iron overload assessment: normal values by age and sex

  2015cites this paper
• Supplementation of Citrus maxima Peel Powder Prevented Oxidative Stress, Fibrosis, and Hepatic Damage in Carbon Tetrachloride (CCl4) Treated Rats

  2015cites this paper
• Iron homeostasis and its regulators over the course of chronic hepatitis C

  2014cites this paper
• Quantification of hepatic fat and iron with magnetic resonance imaging.

  2014cites this paper
• Comparative Salivary Proteome of Hepatitis B- and C-Infected Patients

  2014cites this paper
• Biochemical nutritional profile of liver cirrhosis patients with hepatocellular carcinoma.

  2014cites this paper
• Mechanistic and regulatory aspects of intestinal iron absorption.

  2014cites this paper
• AMPK activation by isorhamnetin protects hepatocytes against oxidative stress and mitochondrial dysfunction.

  2014cites this paper
• of Hepatic Fat and Iron with Magnetic Resonance Imaging

  2014cites this paper
• Role of Oxidative Stress in Hepatitis B and C Virus

  2014cites this paper
• Serum Iron Markers in Patients With Chronic Hepatitis C Infection

  2013cites this paper
• Regulation of iron metabolism during liver injury

  2013cites this paper
• Iron overload and glucose abnormalities in chronic hepatitis C virus infection: phlebotomy lowers risk of new-onset diabetes.

  2013cites this paper
• Iron, Oxidative Stress and Health

  2012cites this paper
• Chapter 64 – Hemochromatosis

  2012cites this paper
• Chapter 71 – Molecular Mechanisms of Intestinal Iron Transport

  2012cites this paper
• Porfiria cutânea tardia com mutações do gene da hemocromatose C282Y e H63D e análise retrospectiva do perfil de ferro em relação ao tratamento: estudo de 60 casos

  2012cites this paper
• Hepatitis C, porphyria cutanea tarda and liver iron: an update

  2012cites this paper
• Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges.

  2012cites this paper
• The effect of liver iron deposition on hepatic apparent diffusion coefficient values in cirrhosis.

  2012cites this paper
• Trace metal imbalance associated with oxidative stress and inflammatory status in anti-hepatitis C virus antibody positive subjects.

  2012cites this paper
• 5 Iron , Oxidative Stress and Health

  2012cites this paper
• Serum ferritin levels in chronic hepatitis C patients during antiviral therapy and prediction of treatment response

  2012cites this paper
• Guidance for Clinical Trials for Children and Adolescents With Chronic Hepatitis C

  2011cites this paper
• Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease

  2011cites this paper
• The changing role of liver biopsy in diagnosis and management of haemochromatosis.

  2011cites this paper
• Pathology of chronic hepatitis B and chronic hepatitis C.

  2010cites this paper
• Iron and Hepatitis C

  2010cites this paper
• How I treat hemochromatosis.

  2010cites this paper
• Gender Difference of Alanine Aminotransferase Elevation May Be Associated with Higher Hemoglobin Levels among Male Adolescents

  2010cites this paper
• Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples

  2010cites this paper